John C. Davis Myeloma and Amyloid Program at Tufts Medical Center’s Cancer Center
The John C. Davis Myeloma and Amyloid Program at Tufts Medical Center’s Cancer Center in Downtown Boston is home to some of the world’s top experts in plasma cell disease detection, treatment and research. Funded by a benefactor who is a multiple myeloma patient, it is focused on ensuring that patients with plasma cell diseases such as myeloma or AL Amyloidosis receive excellent up-to-date patient care and treatment, as well as education and personal and family support.
The program is multi-disciplinary in every sense of the word. The team is made up of hematologists who are plasma cell disease experts, stem cell transplant physicians, kidney, orthopedic and heart specialists, experienced pathologists and radiologists, nurses and nurse practitioners and social workers. The expert nurse practitioners and physicians perform all bone marrow studies and have one of the most experienced stem cell transplant laboratory and nursing staffs in the world.
The mission of the John C. Davis Program at Tufts Medical Center is to treat patients in the most effective ways, to care for them and their families, and to advance the treatment and understanding of plasma cell diseases by means of clinical trials and laboratory research. The John C. Davis Program is also home to the Tufts Medical Center Monoclonal Gammopathy of Renal Significance (MGRS) clinic.
The team includes healthcare professionals in the following areas:
Hematology and Oncology:
Raymond L. Comenzo, MD
